Know Cancer

or
forgot password

Cancer Genome Analysis


N/A
18 Years
N/A
Open (Enrolling)
Both
Malignant Tumor

Thank you

Trial Information

Cancer Genome Analysis


Inclusion Criteria:



- patients with malignant tumor

- receiving or planning to receive chemotherapy

- with fresh frozen tumor tissue

- with informed consent

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

targeted sequencing of cancer-relate genes

Outcome Description:

Identification and characterization of genetic alteration in cancer tissue

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Tae-You Kim

Investigator Role:

Principal Investigator

Investigator Affiliation:

Seoul National University Hospital

Authority:

Republic of Korea: Food and Drug Administration

Study ID:

Cancer genome analysis

NCT ID:

NCT01458704

Start Date:

August 2011

Completion Date:

Related Keywords:

  • Malignant Tumor
  • Neoplasms

Name

Location